Detalan

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

1 API Suppliers, 1 USDMF

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

RELATED EXCIPIENT COMPANIES

Suppliers, 12 Kerry, 10 Corel Pharma Chem, 6 Lonza Capsugel, 6 Seppic, 4 Ideal Cures Pvt Ltd, 3 Gangwal Chemicals, 3 Kima Chemical, 2 Actylis, 2 The Dow Chemical Company, 1 Gangwal Healthcare, 1 Qualicaps, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Microlex e.U, 1 ACG Worldwide, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Nanjing Well Pharmaceutical

EXCIPIENTS BY APPLICATIONS

38 Coating Systems & Additives, 17 Controlled & Modified Release, 5 Film Formers & Plasticizers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Fillers, Diluents & Binders, 3 API Stability Enhancers, 3 Parenteral, 2 Taste Masking, 2 Granulation, 2 Coloring Agents, 1 Disintegrants & Superdisintegrants, 1 Solubilizers, 1 Direct Compression, 1 Emulsifying Agents, 1 Rheology Modifiers, 1 Thickeners and Stabilizers, 1 Co-Processed Excipients, 1 Chewable & Orodispersible Aids

MARKET PLACE

1 APIs, 1 EXCIPIENTS

ANALYTICAL SOLUTION(s)

2 EDQM Standards, 3 USP Standards

DIGITAL CONTENT

1 News

1 News

Full Screen View

Santen Pharmaceutical

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Santen Announces Health Canada Approval for Cationorm® Plus to Relieve the Symptoms of Dry Eye and Ocular Allergy

Details:

Cationorm® Plus (glycerol) is a sterile, preservative-free, artificial tear containing the novel Novasorb® technology. As the only artificial tear that uses positive cationic emulsion to hold hydration in place, it protects, hydrates and lubricates the eye.

Lead Product(s): Glycerine,Tyloxapol API,Detalan

Therapeutic Area: Ophthalmology Product Name: Cationorm Plus

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 06, 2022

ASK
US

Upload
your Marketing & Sales content

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Find Drugs in Development News & Deals for Detalan

Detalan

Detalan

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

1 API Suppliers

1 USDMF

DEVELOPMENTS

1 Drug(s) in Development

RELATED EXCIPIENT COMPANIES

Suppliers

12 Kerry

10 Corel Pharma Chem

6 Lonza Capsugel

6 Seppic

4 Ideal Cures Pvt Ltd

3 Gangwal Chemicals

3 Kima Chemical

2 Actylis

2 The Dow Chemical Company

1 Gangwal Healthcare

1 Qualicaps

1 Qianhao Chemical (Hebei) Co., Ltd

1 Microlex e.U

1 ACG Worldwide

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Nanjing Well Pharmaceutical

EXCIPIENTS BY APPLICATIONS

38 Coating Systems & Additives

17 Controlled & Modified Release

5 Film Formers & Plasticizers

5 Empty Capsules

4 Vegetarian Capsules

4 Fillers, Diluents & Binders

3 API Stability Enhancers

3 Parenteral

2 Taste Masking

2 Granulation

2 Coloring Agents

1 Disintegrants & Superdisintegrants

1 Solubilizers

1 Direct Compression

1 Emulsifying Agents

1 Rheology Modifiers

1 Thickeners and Stabilizers

1 Co-Processed Excipients

1 Chewable & Orodispersible Aids

MARKET PLACE

1 APIs

1 EXCIPIENTS

ANALYTICAL SOLUTION(s)

2 EDQM Standards

3 USP Standards

DIGITAL CONTENT

1 News

API SUPPLIERS

API REF. PRICE (USD / KG)

INTERMEDIATES

DOSSIERS // FDF

GLOBAL SALES (USD Million)

EXCIPIENTS

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

REF STANDARD

SERVICES

Santen Announces Health Canada Approval for Cationorm® Plus to Relieve the Symptoms of Dry Eye and Ocular Allergy

What are you looking for?